NCT00405821View on ClinicalTrials.gov

Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda

PHASE2CompletedINTERVENTIONAL
Enrollment

440

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

October 31, 2010

Study Completion Date

November 30, 2010

Conditions
HIV InfectionsHerpes Genitalis
Interventions
DRUG

Acyclovir

400mg twice daily for 24 months

DRUG

Placebo

Placebo tablet twice daily for 24 months

Trial Locations (1)

Unknown

Rakai Health Sciences Program, Uganda Virus Research Institute, Kalisizo

All Listed Sponsors
collaborator

University of Washington

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

Translational Genomics Research Institute

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00405821 - Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda | Biotech Hunter | Biotech Hunter